- Exchange: -
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Oscient Pharmaceuticals Corp
OSCIQ:US
Ticker Delisted
Snapshot for Oscient Pharmaceuticals Corp (OSCIQ)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for OSCIQ
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2009) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -3.9700 |
| Est. EPS (12/2009) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 39.43 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for OSCIQ
No data available
Company Profile & Key Executives for OSCIQ
Oscient Pharmaceuticals Corporation develops drugs. The Company produces a cardiovascular medication and an antibiotic used to treat bronchitis and pneumonia.
| Philippe M MaitreExec VP/CFO | Anthony WatkinsVP:Corp Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
OSCIQ News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page